Along the same lines, in our study, the expression levels of TGF-β were not found to be significantly modulated in either of the two disorders (with only a trend of reduction—FDR = 0.068 for T2DM and FDR = 0.346 for SCZ). Here, TGFB1 is linked to type 2 diabetes mellitus.